Having trouble accessing articles? Reset your cache.

NPS reports first Gattex sales

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) reported 1Q13 earnings on Thursday, including $654,000 in the

Read the full 135 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE